Navigation Links
Hokusai-VTE study suggests certain sub-groups of venous thromboembolism patients may need review
Date:8/31/2013

AMSTERDAM, The Netherlands In the treatment of venous thromboembolism (VTE), the oral anticoagulant edoxaban resulted in equal efficacy and better safety compared to standard warfarin when either drug was used with initial low molecular weight heparin (LMWH), according to the results of the Hokusai-VTE trial.

In the landscape of new trials with oral anticoagulants, the Hokusai-VTE findings offer fresh insight into a previously under-represented subgroup of patients with pulmonary embolism (PE), suggesting that treatment for this group might need to be different than for other VTE patients, said lead investigator Harry R. Bller, MD, who presented the findings here at the European Society of Cardiology Congress.

"I think our findings are going to shake things up a little bit," said Dr. Bller, from the Department of Vascular Medicine at Academic Medical Center in Amsterdam.

"What makes this study unique is new insight that there are subgroups in which we might need to revisit what we currently think about the treatment of VTE."

The Hokusai-VTE trial included a broader spectrum of VTE patients compared to those included in other recent oral anticoagulant trials, including a large subgroup (30%) of patients with PE and right ventricular dysfunction, and another subgroup (20%) at high risk for bleeding due to renal impairment and low body weight.

In total, 4921 patients with deep-vein thrombosis and 3319 with pulmonary embolism received initial subcutaneous LMWH therapy and were then randomized to receive either 60 mg of edoxaban daily (30 mg for those at higher risk for bleeding, ie., creatinine clearance 30-50 mL/min or body weight below 60 kg), or warfarin (per standard of care) for 3 to 12 months.

For the primary efficacy endpoint of recurrent symptomatic venous thromboembolism, the study found that edoxaban was non-inferior to warfarin , with the primary endpoint of recurrent symptomatic VTE occurring in 3.2% vs
'/>"/>

Contact: ESC Press Office
press@escardio.org
44-773-005-7146
European Society of Cardiology
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Study reveals the face of sleep deprivation
2. Mosquitoes smell you better at night, study finds
3. UC Davis Study Identifies Better Blood Glucose Monitor for Burn Care
4. Medicare Study Examines Mental Health Effect of Superstorm Sandy to Improve Future Disaster Response
5. Japan Savory Snacks Market to Post 3.9% CAGR During 2013-2017, According to Canadean Study Available at MarketPublishers.com
6. St. Jude Childrens Research Hospital study yields new strategy against high-risk leukemia
7. Petra Beli joins IMB, obtains Emmy Noether award to study cellular response to DNA damage
8. Study examines relationship of a commercial ACO contract with medical spending
9. Europe Small Bone & Joint Orthopedic Device Market to See Positive Growth to 2019, According to iData Research Study Available at MarketPublishers.com
10. Study Finds GanedenBC30 Probiotic Supports Digestive and Immune Health in Healthy Seniors
11. World Antibiotic Resistance Market Saw Big Changes in Last Five Years, According to Biopharm Reports Study Available at MarketPublishers.com
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/1/2014)... PA (PRWEB) August 01, 2014 For ... than bottle-feeding. A recent study conducted by ... not lag too far behind in terms of their ... want to know what’s best for their baby. So ... According to Dr. Steven Shapiro , chair of ...
(Date:8/1/2014)... YORK, NY August 1, 2014 The ... trials and first report investigations that will be ... 2014 scientific symposium. TCT, the world,s premier educational ... place September 13 17, 2014 at the ... , Clinical research data presented at TCT often ...
(Date:8/1/2014)... (PRWEB) August 01, 2014 ... Market Outlook to 2020", provides key market ... market. The report provides value, in millions ... average prices (in US dollars) within market ... Ultrasonic Generators and Argon Plasma Coagulation Generators. ...
(Date:8/1/2014)... (PRWEB) August 01, 2014 In today’s ... overall development of an individual. Hence, these methods need ... and employability skills can be inculcated. In this age ... boost to these conventional methods. Thus, learning management systems ... methodologies. , As of now, these are proving ...
(Date:8/1/2014)... FRIDAY, Aug. 1, 2014 (HealthDay News) -- Women who ... drink alcohol than their civilian peers, a new study ... likely to consume alcohol. However, these researchers found that ... than men. This may be due to concerns about ... "Alcohol use is tightly linked to sexual assault, both ...
Breaking Medicine News(10 mins):Health News:Despite Recent Study, Abington Health Expert Encourages Breastfeeding 2Health News:Despite Recent Study, Abington Health Expert Encourages Breastfeeding 3Health News:CRF announces late-breaking trials and first report investigations for TCT 2014 2Health News:CRF announces late-breaking trials and first report investigations for TCT 2014 3Health News:CRF announces late-breaking trials and first report investigations for TCT 2014 4Health News:United Kingdom Surgical Generators Market Size, Share, Analysis, Trends and Forecasts 2020 2Health News:United Kingdom Surgical Generators Market Size, Share, Analysis, Trends and Forecasts 2020 3Health News:North America Learning Management System Market is Expected to Reach $5.13 Billion in 2018 - New Report by MicroMarket Monitor 2Health News:North America Learning Management System Market is Expected to Reach $5.13 Billion in 2018 - New Report by MicroMarket Monitor 3Health News:North America Learning Management System Market is Expected to Reach $5.13 Billion in 2018 - New Report by MicroMarket Monitor 4Health News:Women in Military Drink Less Than Civilians, Report Shows 2
... the University of Warwick and the Indian Institute of Technology ... to transport iron safely through our blood stream can, in ... fibrils banded by lines of iron rust. This process could ... the brain to cause some forms of Parkinsons & Alzheimers ...
... 8 Antidepressant medications,which increase serotonin neurotransmitter ... can increase depression, impulsivity and,suicide risk in ... physicians prescribe serotonin enhancement medications to dopamine,deficient ... and,suicidal," said Dr. Rick Sponaugle, Medical Director ...
... tool powered by SNAPforSeniors(R) helps members quickly,locate safe housing, ... rash of tornadoes in more than 20 years destroyed ... Tennessee Tuesday night., Emergency warnings gave most residents ... housing, natural disasters bring extra fears. Lack,of mobility, limited ...
... NightHawk,Radiology Holdings, Inc. (Nasdaq: NHWK ), a ... United States, announced today that,the time of its fourth ... to February 13, 2008 at 4:30 p.m. (ET). The ... on February 13, 2008., Conference Call & Web ...
... (Nasdaq: MLAB ) today announced that its ... dividend of ten cents per share of common,stock, ... record at the close of,business on February 25, ... markets,electronic instruments for industrial, pharmaceutical and medical,applications., ...
... poorly one year later, study found , , FRIDAY, Feb. 8 ... sufficient reason for most people to change to a heart-healthy ... quality is poor after a coronary heart disease event," said ... at the University of Massachusetts Medical School, in Worcester. , ...
Cached Medicine News:Health News:Iron banded worms drying out of blood could be linked to Parkinson's and Alzheimer's 2Health News:Antidepressants Can Increase Depression, Impulsivity and Suicide Risk by Decreasing Dopamine 2Health News:Antidepressants Can Increase Depression, Impulsivity and Suicide Risk by Decreasing Dopamine 3Health News:Tennessee Tornadoes Spur Senior Move Managers to Aid Elderly in Crisis 2Health News:Tennessee Tornadoes Spur Senior Move Managers to Aid Elderly in Crisis 3Health News:NightHawk Radiology Holdings, Inc. Announces Time Change for Fourth Quarter and Full-Year 2007 Earnings Conference Call 2Health News:Heart Attack Seldom Leads to Healthier Diet 2Health News:Heart Attack Seldom Leads to Healthier Diet 3
(Date:7/31/2014)... July 31, 2014  Alexza Pharmaceuticals, Inc. (Nasdaq: ... on its pipeline and new product development efforts. In ... initiate a Phase 2a study of AZ-002 (Staccato ... the management of patients with acute repetitive seizures. ... -based product candidates for development - AZ-008 and ...
(Date:7/31/2014)... , July 31, 2014 Rock Creek ... that it has initiated the development of its lead ... and that it has selected Quotient Clinical, The Translational ... (UK) to run its early development programs. ... Trial Application (CTA) by the end of the third ...
(Date:7/31/2014)... BURLINGTON, Mass. , July 31, 2014 /PRNewswire/ ... committee members—who make decisions about which therapies are ... influence formulary placement, according to a new Manhattan ... Makers 2014 . The study finds that P&T ... and pharmacy benefits managers (PBMs) have set a ...
Breaking Medicine Technology:Alexza Provides Pipeline Update 2Alexza Provides Pipeline Update 3Alexza Provides Pipeline Update 4Alexza Provides Pipeline Update 5Alexza Provides Pipeline Update 6Rock Creek Pharmaceuticals Provides Update of its European Drug Development Regulatory Strategy and selects Quotient Clinical for its early development programs 2Rock Creek Pharmaceuticals Provides Update of its European Drug Development Regulatory Strategy and selects Quotient Clinical for its early development programs 3Rock Creek Pharmaceuticals Provides Update of its European Drug Development Regulatory Strategy and selects Quotient Clinical for its early development programs 4Formulary Decision Makers Say Pharma-Provided Patient Support Solutions Influence Formulary Placement 2Formulary Decision Makers Say Pharma-Provided Patient Support Solutions Influence Formulary Placement 3
... 23, 2012  Doctors and other healthcare professionals have grown increasingly ... is taking with regard to Fosamax - a widely used ... fractures. The FDA has so far resisted ... prolonged use. Such labels are necessary in light of the ...
... BEIJING, Feb. 23, 2012 /PRNewswire-Asia-FirstCall/ -- Dehaier Medical ... an emerging leader in the development, assembly, marketing and ... announced that for the year ended December 31, 2011, ... led by the Ministry of Science and Technology of ...
Cached Medicine Technology:Victims of Abnormal Bone Fractures Await Action as FDA Lingers on Edge of Tightening Fosamax Regulations 2Dehaier Medical Received Government Subsidy as a Certified High Technology Enterprise 2Dehaier Medical Received Government Subsidy as a Certified High Technology Enterprise 3
Pipetman F is a fixed-volume, air-displacement pipette. Thirteen robust models cover a large volume range from 2 L to 1000 L, with Gilsons legendary accuracy and precision....
Inquire...
... new Finnpipette Focus from Thermo ... combine ergonomics with uncompromising performance. ... plate offers a custom fit ... new shorter tip cones allow ...
Inquire...
Medicine Products: